PROLIXIN ENANTHATE Drug Patent Profile
When do Prolixin Enanthate patents expire, and what generic alternatives are available?
Prolixin Enanthate is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in PROLIXIN ENANTHATE is fluphenazine enanthate. There is one drug master file entry for this compound. Additional details are available on the fluphenazine enanthate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROLIXIN ENANTHATE?
- What are the global sales for PROLIXIN ENANTHATE?
- What is Average Wholesale Price for PROLIXIN ENANTHATE?
Summary for PROLIXIN ENANTHATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Patent Applications: | 950 |
| DailyMed Link: | PROLIXIN ENANTHATE at DailyMed |
US Patents and Regulatory Information for PROLIXIN ENANTHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | PROLIXIN ENANTHATE | fluphenazine enanthate | INJECTABLE;INJECTION | 016110-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
